Metabolic
Glycomacropeptide and essential amino acids with vitamins and minerals
Brand: PKU Build 10
PBAC's latest decision on Glycomacropeptide and essential amino acids with vitamins and minerals: Recommended (2024). Considered for Dietary management of phenylketonuria (PKU).
PBAC outcome
Recommended
Restricted
ICER (AUD/QALY)
Cost-min
cost-minimisation analysis
Submissions
14
first 2015
Submissions
14
2015 → 2024
Eligible population Patients with phenylketonuria (PKU) requiring dietary management.
Therapy area Metabolic Line of therapy Not applicable Evidence base Cost-minimisation Primary endpoint Cost-minimisation Comparator 60-pack PKU Build 10 (currently listed), PKU Build 20, Camino Pro Bettermilk, PKU Restore, PKU Glytactin RTD 15 Economic model Cost-minimisation ICER note Cost-minimisation analysis; no ICER calculated. Submission requested same DPMQ as currently PBS-listed 60-pack size.
Submission history Mar 2015 : Recommended · RestrictedJul 2015 : Recommended with restriction · RestrictedNov 2015 : Recommended · RestrictedJul 2016 : Recommended · RestrictedNov 2016 : Recommended with restriction · RestrictedNov 2017 : Recommended · RestrictedNov 2017 : Recommended · RestrictedNov 2018 : Recommended with restriction · RestrictedJul 2019 : Recommended · RestrictedNov 2019 : Recommended · RestrictedJul 2020 : Recommended with restriction · RestrictedMar 2023 : Recommended with restriction · RestrictedMar 2023 : Recommended · RestrictedNov 2024 : Recommended · Restricted
Similar precedents
Open on full dashboard →
Part of script.report — an independent tracker of every PBAC Public Summary Document and the PBS expenditure that follows. Built from public data on pbs.gov.au . Not affiliated with the Australian Department of Health, PBAC, or any pharmaceutical company.
script.report extracts information discussed in PBAC Public Summary Documents (PSDs), not independently calculated values. Where figures such as ICERs are shown, they reflect what was discussed or referenced in committee documentation — not confirmed inputs. For authoritative cost-effectiveness data, refer to the original PSD.